Eisai (OTCMKTS:ESALY) Earns Outperform Rating from Analysts at Sanford C. Bernstein

Sanford C. Bernstein initiated coverage on shares of Eisai (OTCMKTS:ESALYGet Rating) in a research report report published on Tuesday, The Fly reports. The firm issued an outperform rating on the stock.

Eisai Stock Down 2.1 %

Eisai stock opened at $61.51 on Tuesday. The stock has a market cap of $17.64 billion, a price-to-earnings ratio of 70.70, a PEG ratio of 2.46 and a beta of 0.31. Eisai has a 52 week low of $36.88 and a 52 week high of $73.90. The company has a current ratio of 2.20, a quick ratio of 1.77 and a debt-to-equity ratio of 0.10. The company’s 50-day moving average price is $61.51 and its two-hundred day moving average price is $63.21.

Eisai Company Profile

(Get Rating)

Eisai Co, Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs.

Read More

The Fly logo

Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.